- Home
- PLAO vs ASRT Comparison
PLAO vs ASRT Comparison
Compare PLAO & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLAO
- ASRT
- Stock Information
- Founded
- PLAO 2021
- ASRT 1995
- Country
- PLAO Cayman Islands
- ASRT United States
- Employees
- PLAO N/A
- ASRT N/A
- Industry
- PLAO Blank Checks
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- PLAO Finance
- ASRT Health Care
- Exchange
- PLAO Nasdaq
- ASRT Nasdaq
- Market Cap
- PLAO 119.5M
- ASRT 123.9M
- IPO Year
- PLAO 2022
- ASRT 1997
- Fundamental
- Price
- PLAO $11.60
- ASRT $1.10
- Analyst Decision
- PLAO
- ASRT Strong Buy
- Analyst Count
- PLAO 0
- ASRT 5
- Target Price
- PLAO N/A
- ASRT $3.35
- AVG Volume (30 Days)
- PLAO 4.8K
- ASRT 435.5K
- Earning Date
- PLAO 01-01-0001
- ASRT 11-06-2024
- Dividend Yield
- PLAO N/A
- ASRT N/A
- EPS Growth
- PLAO 14.37
- ASRT N/A
- EPS
- PLAO 0.38
- ASRT N/A
- Revenue
- PLAO N/A
- ASRT $132,186,000.00
- Revenue This Year
- PLAO N/A
- ASRT N/A
- Revenue Next Year
- PLAO N/A
- ASRT $4.68
- P/E Ratio
- PLAO $30.64
- ASRT N/A
- Revenue Growth
- PLAO N/A
- ASRT N/A
- 52 Week Low
- PLAO $10.97
- ASRT $0.73
- 52 Week High
- PLAO $12.06
- ASRT $2.53
- Technical
- Relative Strength Index (RSI)
- PLAO 56.13
- ASRT 38.68
- Support Level
- PLAO $11.58
- ASRT $1.15
- Resistance Level
- PLAO $11.62
- ASRT $1.25
- Average True Range (ATR)
- PLAO 0.00
- ASRT 0.06
- MACD
- PLAO -0.00
- ASRT -0.01
- Stochastic Oscillator
- PLAO 47.62
- ASRT 4.00
About PLAO Patria Latin American Opportunity Acquisition Corp.
Patria Latin American Opportunity Acquisition Corp is a blank check company.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.